Downregulation of DOM decreases the abundance of PER and TIM. by Zhenxing Liu (399809)

“…Downregulation of DOM decreased PER levels at CT1-5 and CT17-21. (Scale bar: 50 um.) …”

Phlorizin decreased renal GTTR uptake, and increased serum drug levels <i>in vivo</i>. by Meiyan Jiang (438439)

Decreased epithelial PGR expression in <i>Arid1a</i>^<i>d/d</i> mice. by Tae Hoon Kim (128536)

Androgen and staurosporine synergize to decrease the relative ATP concentration in HPr-1AR cells. by Congcong Chen (796149)

“…In comparison to vehicle control, STS and to a lesser extent DHT significantly decrease the relative ATP concentration of HPr-1AR cells at 24 hours. …”

Glucagon receptor (GcgR) antagonism decrease α-cell proliferation. by Zhuo Liu (357070)

PKCδ inhibition decreases CXCL4-induced cord dissociation. by Joshua Jamison (470566)

Reductions in MEF2 expression do not impair PGE₂ decrease of <i>Sost</i>. by Damian C. Genetos (325684)

The estrogen receptor-α agonist PPT decreases cardiac myofilament activation. by Justyna Kulpa (313372)

“…<p>Myocardium was treated with the estrogen receptor-α agonist PPT (100 nM) for 1 (A) (N = 9), 2.5 (B) (N = 9), or 5 min (C) (N = 22). …”

Over-expression of rhodopsin decreased the expression levels of differentiation markers in NHEKs. by Hyoung-June Kim (459814)

GFP activity is decreased in DES. by Céline Portal (3876436)

“…<p><b>(a)</b> Scatterplots show that CGC number determined on histological sections (AB—PAS coloration), and GFP⁺ (Muc5b) and Muc5ac⁺ CGC number determined by immunofluorescence staining (anti-GFP and anti-Muc5ac antibody) decreased (n = 10 mice, 1 section per mouse, one symbol/mouse) after 10 days of BAK application (filled-in symbols) in one eye (PBS in the other, white-filled symbols) followed by 4 days without any treatment. …”

Blocking TCF transcriptional activity decreased CFZ-induced MSC differentiation. by Bo Hu (126105)

<i>E. faecalis</i> metabolism decreases after exposure to bilirubin. by Christopher L. Nobles (437464)

Increased miR200c decreases FAP-1 expression. by Sabarinathan Ramachandran (444500)

Inhibition of NM-2 activity through drug treatments produces decreased FM1-43 internalization. by Juan A. Flores (587973)

Inhibition of NM-2 activity through drug treatments produces decreased FM1-43 internalization. by Juan A. Flores (587973)

Inhibition of ABCG2 decreases SP cells, but not sphere-forming ability. by Noriko Kawai (6694010)

EphA4 immunostaining is decreased adjacent to injury site in ephrin-A5-Fc treated mice. by Yona Goldshmit (205708)

“…<p>Immunohistochemical analysis of (A,B) GFAP, (C–F) EphA4 and (G,H) CSPG expression at 2 weeks after spinal cord hemisection and 2 weeks of ephrin-A5-Fc treatment indicated that there was robust GFAP staining in both treated and control mice (A,B). …”

Decreased Sho levels in ScN2a-Sho cells. by Joel C. Watts (195735)

“…(<b>C</b>) Quantification of Sho levels in ScN2a-Sho-1 (<i>n</i> = 10) and ScN2a-Sho-2 (<i>n</i> = 5) subclones revealed a significant decrease of 40–45% compared to the uninfected parental cell line (<i>n</i> = 15) (***<i>P</i><0.001).…”

Treatment with IVIg is associated with a transient decrease in levels of PFR-MCA hydrolyzing IgG. by Ankit Mahendra (446529)

Novel chromobox 2 inhibitory peptide decreases tumor progression by Lindsay W. Brubaker (15099942)